This week, settlement recovery service MCAG, a HASC Endorsed Business Partner, announces the following settlements – with accompanying application deadlines.

To learn more about MCAG’s services, contact Darryl Sanford, HASC Director, Member Relations & Association Services (below).

• Visa/Mastercard Interchange Fee Class Action Settlement: $6.2 billion. No deadline yet – but MCAG expects to learn more by Nov. 7. Members that used the credit cards to process transactions during the previous 14 years are eligible.
   
• Provigil Pharmaceutical Settlement: $65.8 million. Application deadline is Jan. 15. This settlement is for self-insured members that purchased Provigil for their employee benefits plan (not patients).
   
• Thalomid and Revlimid Settlement: $55 million. Application deadline is Dec. 15. As above, this settlement is for self-insured members that purchased the listed medications for their employee benefits plan (not patients).
   
• Automotive Parts Settlements: $1.2 billion. Application deadline is Dec. 31. Members that purchased or leased automobiles in the January 1995 to March 2018 timeframe are eligible.

HASC members can easily enroll for MCAG’s services here.

Contact:
Darryl Sanford
(213) 538-0772
dsanford@hasc.org

Payment Card Settlement Disclaimer: On Jan. 24, 2019 the Court granted preliminary approval of the Visa/Mastercard settlement filed on Sept. 18, 2018 for the Rule 23(b)(3) Class Plaintiffs in this action. No claim forms are available at this time, and no claim-filing deadline exists. If the settlement is granted final approval, no-cost assistance will be available from the Class Administrator and Class Counsel during any claims-filing period. No one is required to sign up with any third-party service in order to participate in any settlement. For additional information regarding the status of the litigation, interested persons may visit www.paymentcardsettlement.com, the Court-approved website for this case.